Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

  Hologic Inc ( HOLX ) |
1995 - 2021 (27 years)

Net Revenue (Sales) is 
$5.4B (1Y +35.8% )

HOLX Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for HOLX competitors.
DGX ABT BDX BSX GE JNJ TMO PHG
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $2.8B +116x
( +19.3% / year avg)
chevron_left 1995 $24.2M
vertical_align_top Peak $3.5B +143x
vertical_align_bottom Bottom $24.2M
arrow_drop_up # Up Years 21 21 of 27
years up.
arrow_drop_down # Down Years 6
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • HOLX's stock price has rallied +2,487% from $2.34 in 1995 , or +0.21x the rate relative to it's net revenue (sales) over the same period.
  • If HOLX grows it's stock at the same rate as it's net revenue (sales) (+19.3%/year) , it's stock price will grow +583% and hit $354.19 over the next 10 years.
  • HOLX's stock price has gone up 15 of the 21 years (+71%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996
    1 Revenue 1122000.00 3367300000.00 3217900000.00 3058800000.00 2832700000.00 2705000000.00 2530700000.00 2492300000.00 2002600000.00 1789300000.00 1679600000.00 1637100000.00 1674500000.00 738400000.00 462680000.00 287700000.00 228700000.00 204000000.00 190200000.00 180200000.00 93746000.00 84700000.00 115600000.00 106700000.00 91600000.00
    2 Cost of Revenue -1105000.00 1617700000.00 1521200000.00 1437800000.00 1269400000.00 1272300000.00 1258600000.00 1329200000.00 1008200000.00 866200000.00 942900000.00 779600000.00 782000000.00 393000000.00 269148000.00 175800000.00 144400000.00 130500000.00 118400000.00 119400000.00 59184000.00 51900000.00 55900000.00 47500000.00 41300000.00
    3 Gross Profit (Income) 2227000.00 1749600000.00 1696700000.00 1621000000.00 1563300000.00 1432700000.00 1272100000.00 1163100000.00 994400000.00 923200000.00 736600000.00 857500000.00 892500000.00 345300000.00 193532000.00 111900000.00 84300000.00 73600000.00 71800000.00 60800000.00 34562000.00 32700000.00 59700000.00 59200000.00 50300000.00
    4 R&D 222000.00 232200000.00 218700000.00 232800000.00 232100000.00 214900000.00 203200000.00 197600000.00 135500000.00 116700000.00 104300000.00 102500000.00 88200000.00 44400000.00 28294000.00 18500000.00 16500000.00 18400000.00 20400000.00 23300000.00 17178000.00 12700000.00 9800000.00 8500000.00 7300000.00
    5 SG&A -128000.00 332300000.00 366100000.00 343300000.00 267300000.00 261000000.00 259800000.00 227663000.00 220486000.00 159570000.00 148326000.00 140723000.00 140676000.00 62755000.00 0.00 26501000.00 23539000.00 22222000.00 47200000.00 54700000.00 40323000.00 29500000.00 39000000.00 28300000.00 25600000.00
    6 Other Expenses 0.00 165300000.00 805200000.00 12900000.00 100200000.00 0.00 0.00 80000000.00 81000000.00 20000000.00 0.00 0.00 -1215000.00 -2078000.00 0.00 -155000.00 -199000.00 -445000.00 0.00 0.00 0.00 0.00 0.00 0.00 1900000.00
    7 Operating Expenses 1062000.00 1874200000.00 1980500000.00 1137200000.00 1020000000.00 1040300000.00 999800000.00 2078500000.00 923000000.00 578600000.00 666700000.00 2874200000.00 1090000000.00 197600000.00 123293000.00 79300000.00 71700000.00 70500000.00 69600000.00 79600000.00 61921000.00 42300000.00 48800000.00 36800000.00 35600000.00
    8 Interest Expense 116000.00 140800000.00 148700000.00 153200000.00 155300000.00 205500000.00 220600000.00 281075000.00 140287000.00 114846000.00 127107000.00 69502000.00 84912000.00 2078000.00 0.00 155000.00 199000.00 445000.00 600000.00 1000000.00 0.00 4200000.00 6000000.00 5300000.00 2600000.00
    9 D&A 83000.00 463100000.00 480300000.00 62500000.00 465400000.00 491400000.00 523200000.00 516000000.00 345800000.00 304700000.00 294800000.00 273900000.00 172900000.00 31200000.00 1631000.00 7600000.00 7600000.00 7400000.00 7500000.00 8700000.00 4420000.00 3500000.00 1900000.00 1300000.00 900000.00
    10 EBITDA 1188000.00 338500000.00 196500000.00 546300000.00 1008700000.00 883800000.00 795500000.00 -399400000.00 417200000.00 649300000.00 364700000.00 -1742800000.00 -24600000.00 179000000.00 71870000.00 40200000.00 20200000.00 10400000.00 9700000.00 -10100000.00 -22939000.00 -6000000.00 12800000.00 23700000.00 15600000.00
    11 Operating Income 1105000.00 -124600000.00 -283800000.00 483800000.00 543300000.00 392400000.00 272300000.00 -915400000.00 71400000.00 344600000.00 69900000.00 -2016700000.00 -197500000.00 147800000.00 70239000.00 32600000.00 12600000.00 3000000.00 2200000.00 -18800000.00 -27359000.00 -9500000.00 10900000.00 22400000.00 14700000.00
    12 Other Income Expenses (Net) 9000.00 -5800000.00 7600000.00 896100000.00 26200000.00 -11000000.00 -4900000.00 2300000.00 4900000.00 -4200000.00 900000.00 -3700000.00 -1200000.00 400000.00 -14807000.00 200000.00 100000.00 -400000.00 -3000000.00 -2900000.00 -5227000.00 -500000.00 -700000.00 -200000.00 -200000.00
    13 Pre-Income Tax 1001000.00 -257700000.00 -418600000.00 1230500000.00 415300000.00 177200000.00 48100000.00 -1192900000.00 -61700000.00 227400000.00 -55000000.00 -2154100000.00 -327300000.00 148500000.00 53223000.00 34700000.00 12900000.00 3300000.00 -300000.00 -20700000.00 -29019000.00 -5800000.00 16200000.00 27600000.00 17100000.00
    14 Income Tax Expense 0.00 -59100000.00 -307300000.00 475000000.00 84500000.00 45600000.00 30800000.00 -20123000.00 11973000.00 70236000.00 7822000.00 87562000.00 106476000.00 53911000.00 25800000.00 6439000.00 763000.00 176000.00 -400000.00 200000.00 -10400000.00 -2100000.00 5800000.00 9800000.00 5700000.00
    15 Net Income 1110000.00 -203600000.00 -111300000.00 755500000.00 330800000.00 131600000.00 17300000.00 -1172800000.00 -73600000.00 157200000.00 -62800000.00 -2216600000.00 -415600000.00 94600000.00 27423000.00 28300000.00 12200000.00 2900000.00 200000.00 -20900000.00 -18619000.00 -3700000.00 10400000.00 17700000.00 11400000.00
    16 EPS 0.00 -0.76 -0.40 2.70 1.16 0.45 0.06 -4.36 -0.28 0.59 -0.24 -8.64 -1.69 0.86 0.29 0.31 0.14 0.04 0.00 -0.34 -0.30 -0.07 0.19 0.32 0.23
    17 EPS Diluted 0.00 -0.76 -0.40 2.64 1.16 0.45 0.06 -4.36 -0.28 0.59 -0.24 -8.64 -1.69 0.86 0.28 0.31 0.14 0.04 0.00 -0.34 -0.30 -0.07 0.19 0.32 0.23
    18 Shares Outstanding 261047000 269413000 275105000 279811000 286156000 289537000 278400000 268700000 264000000 264300000 258700000 256500000 246000000 109700000 93024000 90300000 85200000 80500000 76800000 61900000 61280000 55800000 55100000 54700000 50100000
    19 Shares Outstanding (Diluted) 261047000 269413000 275105000 285653000 286156000 289537000 278400000 268700000 264000000 264300000 258700000 256500000 246000000 109700000 97240000 90300000 85200000 80500000 76800000 61900000 61280000 55800000 55100000 54700000 50100000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996
    1 Cash & Cash Equivalents 701000.00 601800000.00 666700000.00 540600000.00 548400000.00 491300000.00 736000000.00 823000000.00 560000000.00 712000000.00 516000000.00 293000000.00 96000000.00 100000000.00 29923000.00 114000000.00 68000000.00 45000000.00 46000000.00 13000000.00 22778000.00 37000000.00 48000000.00 28000000.00 29000000.00
    2 Short Term Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 26000000.00 27000000.00 56000000.00 47000000.00
    3 Cash & S-T Investments 701000.00 601800000.00 666700000.00 540600000.00 548400000.00 491300000.00 736000000.00 823000000.00 560000000.00 712000000.00 516000000.00 293000000.00 96000000.00 100000000.00 29923000.00 114000000.00 68000000.00 45000000.00 46000000.00 13000000.00 22778000.00 63000000.00 75000000.00 84000000.00 76000000.00
    4 Accounts Receivables 1028000.00 648700000.00 579200000.00 533500000.00 447000000.00 416100000.00 396000000.00 409000000.00 409000000.00 319000000.00 283000000.00 263000000.00 321000000.00 153000000.00 108566000.00 58000000.00 48000000.00 44000000.00 39000000.00 42000000.00 50580000.00 28000000.00 29000000.00 29000000.00 22000000.00
    5 Inventory 395000.00 444900000.00 384100000.00 331600000.00 274700000.00 283100000.00 331000000.00 289000000.00 367000000.00 231000000.00 192000000.00 180000000.00 175000000.00 105000000.00 93477000.00 45000000.00 40000000.00 43000000.00 38000000.00 39000000.00 39706000.00 18000000.00 20000000.00 13000000.00 11000000.00
    6 Other Current Assets 98000.00 97700000.00 93200000.00 72900000.00 56500000.00 75300000.00 103000000.00 103000000.00 227000000.00 81000000.00 108000000.00 83000000.00 102000000.00 41000000.00 0.00 11000000.00 10000000.00 10000000.00 15000000.00 6000000.00 3041000.00 6000000.00 7000000.00 5000000.00 4000000.00
    7 Total Current Assets 2222000.00 1793100000.00 1723200000.00 1478600000.00 1326600000.00 1265800000.00 1566000000.00 1624000000.00 1563000000.00 1343000000.00 1099000000.00 819000000.00 694000000.00 399000000.00 290022000.00 228000000.00 166000000.00 142000000.00 138000000.00 100000000.00 116105000.00 115000000.00 132000000.00 131000000.00 113000000.00
    8 PP&E 491000.00 470900000.00 478200000.00 491200000.00 460200000.00 457100000.00 462000000.00 492000000.00 508000000.00 239000000.00 252000000.00 278000000.00 284000000.00 70000000.00 61723000.00 33000000.00 33000000.00 32000000.00 29000000.00 60000000.00 62794000.00 50000000.00 26000000.00 5000000.00 4000000.00
    9 Goodwill 2657000.00 2563700000.00 2533200000.00 3171200000.00 2803100000.00 2808200000.00 2811000000.00 2815000000.00 3943000000.00 2290000000.00 2109000000.00 2109000000.00 4450000000.00 408000000.00 341994000.00 6000000.00 6000000.00 6000000.00 6000000.00 6000000.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 1307000.00 1459800000.00 2398600000.00 2753900000.00 2643400000.00 3023200000.00 3434000000.00 3907000000.00 4301000000.00 2091000000.00 2119000000.00 2423000000.00 2630000000.00 174000000.00 158161000.00 5000000.00 6000000.00 8000000.00 10000000.00 12000000.00 19137000.00 0.00 0.00 0.00 0.00
    11 Goodwill & Intangible Assets 3964000.00 4023500000.00 4931800000.00 5925100000.00 5446500000.00 5831400000.00 6245000000.00 6722000000.00 8244000000.00 4381000000.00 4228000000.00 4532000000.00 7080000000.00 582000000.00 500155000.00 11000000.00 12000000.00 14000000.00 16000000.00 18000000.00 19137000.00 0.00 0.00 0.00 0.00
    12 L-T Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 0.00 275300000.00 498200000.00 9100000.00 982600000.00 1178400000.00 1375000000.00 1535000000.00 1772000000.00 957000000.00 956000000.00 1045000000.00 921000000.00 55000000.00 0.00 1000000.00 2000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 0.00 154600000.00 97700000.00 31600000.00 83700000.00 88200000.00 143000000.00 164000000.00 162000000.00 41000000.00 47000000.00 56000000.00 77000000.00 16000000.00 4305000.00 7000000.00 0.00 1000000.00 1000000.00 18000000.00 21619000.00 10000000.00 15000000.00 9000000.00 6000000.00
    15 Total Non-Current Assets 4455000.00 4649000000.00 5507700000.00 6501000000.00 5990400000.00 6376700000.00 6849000000.00 7377000000.00 8914000000.00 4666000000.00 4527000000.00 4865000000.00 7441000000.00 667000000.00 566183000.00 52000000.00 46000000.00 47000000.00 46000000.00 95000000.00 103550000.00 61000000.00 41000000.00 14000000.00 10000000.00
    16 Other Assets 518000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 7195000.00 6442100000.00 7230900000.00 7979600000.00 7317000000.00 7642500000.00 8415000000.00 9001000000.00 10477000000.00 6009000000.00 5626000000.00 5684000000.00 8135000000.00 1066000000.00 856205000.00 280000000.00 212000000.00 189000000.00 184000000.00 195000000.00 219655000.00 176000000.00 173000000.00 145000000.00 123000000.00
    18 Accounts Payables 178000.00 186500000.00 192200000.00 166600000.00 156900000.00 117000000.00 92000000.00 81000000.00 87000000.00 63000000.00 57000000.00 47000000.00 60000000.00 42000000.00 26443000.00 14000000.00 11000000.00 11000000.00 11000000.00 18000000.00 16414000.00 6000000.00 5000000.00 5000000.00 4000000.00
    19 S-T Debt 2713000.00 0.00 0.00 805800000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55000000.00 0.00 0.00 0.00 0.00 2000000.00 388000.00 1000000.00 4000000.00 0.00 3000000.00
    20 Income Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 186000.00 179500000.00 172900000.00 171200000.00 161400000.00 163100000.00 150900000.00 132319000.00 129688000.00 120656000.00 120516000.00 52165000.00 53660000.00 29356000.00 30903000.00 21134000.00 13013000.00 9440000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities 875000.00 235700000.00 230300000.00 0.00 199800000.00 176400000.00 161000000.00 172000000.00 150000000.00 154000000.00 214000000.00 107000000.00 88000000.00 46000000.00 0.00 16000000.00 13000000.00 9000000.00 9000000.00 9000000.00 46281000.00 9000000.00 14000000.00 5000000.00 2000000.00
    23 Total Current Liabilities 1239000.00 1070100000.00 1402600000.00 1865500000.00 901900000.00 943400000.00 620000000.00 1088000000.00 661000000.00 509000000.00 442000000.00 329000000.00 341000000.00 179000000.00 174279000.00 56000000.00 43000000.00 38000000.00 39000000.00 55000000.00 63083000.00 25000000.00 32000000.00 18000000.00 16000000.00
    24 L-T Debt 324000.00 2802800000.00 2725500000.00 2172100000.00 3049400000.00 3221000000.00 4153000000.00 4242000000.00 4971000000.00 1489000000.00 1447000000.00 1514000000.00 2162000000.00 9000000.00 6163000.00 0.00 0.00 2000000.00 2000000.00 28000000.00 25000000.00 0.00 0.00 0.00 0.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997 FY 1996
    1 Net Income (Earnings) 1110000.00 -203600000.00 -111300000.00 755500000.00 330800000.00 131600000.00 17300000.00 -1172800000.00 -73600000.00 157200000.00 -62800000.00 -2216600000.00 -415600000.00 94600000.00 27423000.00 28300000.00 12200000.00 2900000.00 200000.00 -20900000.00 -18619000.00 -3700000.00 10400000.00 17700000.00 11400000.00
    2 D&A 83000.00 463100000.00 480300000.00 449200000.00 465400000.00 491400000.00 523200000.00 516000000.00 345800000.00 304700000.00 294800000.00 273900000.00 172900000.00 31200000.00 16133000.00 7600000.00 7600000.00 7400000.00 7500000.00 8700000.00 4420000.00 3500000.00 1900000.00 1300000.00 900000.00
    3 Deferred Income Tax -94000.00 -235700000.00 -477300000.00 -357200000.00 -155800000.00 -148800000.00 -243100000.00 -198000000.00 -155200000.00 -48100000.00 -121700000.00 -27000000.00 -28500000.00 5900000.00 -5797000.00 -100000.00 -2400000.00 -1300000.00 3900000.00 300000.00 -10546000.00 -2100000.00 -2500000.00 200000.00 -1100000.00
    4 Stock-Based Compensation (SBC) 83000.00 62000000.00 65000000.00 68200000.00 65400000.00 59300000.00 50000000.00 52307000.00 40572000.00 35472000.00 34160000.00 32939000.00 0.00 6104000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 Change in Working Capital -722017000.00 402400000.00 707500000.00 -811600000.00 102300000.00 -623600000.00 410000000.00 -366000000.00 68000000.00 177000000.00 167000000.00 137000000.00 133000000.00 104257000.00 -56257000.00 49000000.00 19000000.00 5000000.00 54000000.00 -8022000.00 -36978000.00 -10000000.00 -13000000.00 16000000.00 77600000.00
    6 Accounts Receivables -427000.00 -76500000.00 -38200000.00 -41500000.00 -31800000.00 -30300000.00 7900000.00 4102000.00 -11005000.00 -17131000.00 -20211000.00 57581000.00 0.00 -39270000.00 0.00 -9310000.00 48409000.00 0.00 3000000.00 9000000.00 0.00 1000000.00 0.00 -7000000.00 -8000000.00
    7 Inventory -25000.00 -63000000.00 -50600000.00 -11600000.00 7600000.00 43900000.00 -44700000.00 25165000.00 -12174000.00 -32158000.00 -5247000.00 1167000.00 0.00 -7997000.00 -23023000.00 -4381000.00 40174000.00 0.00 1000000.00 1000000.00 836000.00 2000000.00 -7000000.00 -2000000.00 -2000000.00
    8 Accounts Payables -4000.00 -5500000.00 23900000.00 -10600000.00 40100000.00 25500000.00 11800000.00 -6406000.00 3768000.00 2589000.00 7151000.00 -12881000.00 0.00 14265000.00 0.00 3623000.00 10546000.00 0.00 7000000.00 -2000000.00 0.00 -1000000.00 0.00 -1000000.00 0.00
    9 Other Working Capital 983000.00 723000000.00 320600000.00 -386900000.00 424700000.00 322400000.00 946000000.00 536000000.00 902000000.00 834000000.00 657000000.00 490000000.00 353000000.00 220000000.00 115743000.00 172000000.00 123000000.00 104000000.00 99000000.00 45000000.00 53022000.00 90000000.00 100000000.00 113000000.00 97000000.00
    10 Other Non-Cash Items 0.00 782000000.00 867400000.00 58200000.00 101400000.00 224100000.00 166500000.00 1284100000.00 225100000.00 55500000.00 347900000.00 2463400000.00 650200000.00 -15300000.00 -3549000.00 8500000.00 900000.00 200000.00 300000.00 -1000000.00 0.00 200000.00 300000.00 300000.00 -300000.00
    11 Net Cash Provided by Operating Activities 701000.00 649500000.00 732900000.00 8300000.00 798200000.00 796800000.00 508400000.00 493800000.00 370200000.00 456000000.00 456700000.00 550500000.00 362200000.00 153900000.00 31124000.00 45200000.00 26600000.00 4700000.00 7000000.00 -10300000.00 -677000.00 2300000.00 14600000.00 12600000.00 1100000.00
    12 Investments in PP&E -98000.00 -57000000.00 -58400000.00 -107600000.00 -47300000.00 48100000.00 -44300000.00 -48954000.00 -33149000.00 -27785000.00 -28010000.00 -31357000.00 -78900000.00 -22840000.00 -40583000.00 -7699000.00 -7200000.00 -9200000.00 -6100000.00 -4300000.00 -5821000.00 -8900000.00 -22600000.00 -2100000.00 -2400000.00
    13 Acquisitions (Net) -119000.00 -110600000.00 -76500000.00 307000000.00 0.00 0.00 0.00 -6273000.00 -3762403000.00 -198744000.00 -84322000.00 0.00 2584947000.00 -9793000.00 -172000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Purchase of Investments 0.00 -200100000.00 -275800000.00 0.00 -250000000.00 0.00 0.00 -3725000.00 -250000.00 -99000.00 -795000.00 -550000.00 0.00 -1000000.00 0.00 0.00 0.00 0.00 0.00 0.00 -20938000.00 0.00 0.00 0.00 0.00
    15 Sales/Maturities of Investments 0.00 0.00 0.00 87100000.00 0.00 0.00 0.00 2104000.00 0.00 0.00 678000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50074000.00 0.00 0.00 0.00 0.00
    16 Other Investing Activities 0.00 87000000.00 215500000.00 -600000.00 228900000.00 -134200000.00 -22700000.00 75602000.00 -54982000.00 -39959000.00 45469000.00 0.00 0.00 0.00 -765000.00 0.00 0.00 0.00 0.00 0.00 -5218000.00 0.00 0.00 0.00 0.00
    17 Net Cash used for Investing Activities -141000.00 -280700000.00 -195200000.00 285800000.00 -68400000.00 -86100000.00 -67000000.00 18800000.00 -3850800000.00 -266600000.00 -67000000.00 -65600000.00 -2677100000.00 -59900000.00 -206676000.00 -14300000.00 -7400000.00 -7900000.00 25100000.00 -4700000.00 -12101000.00 -11100000.00 -600000.00 -12100000.00 -50600000.00
    18 Debt Repayment -3000.00 -1462500000.00 -1359400000.00 -529500000.00 -75000000.00 -3095000000.00 -595000000.00 -265000000.00 6071000.00 -6154000.00 -3772000.00 17925000.00 40971000.00 8344000.00 0.00 1118000.00 0.00 178000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    19 Common Stock Issued 65000.00 49000.00 33000000.00 0.00 38000000.00 70000000.00 81000000.00 28594000.00 0.00 0.00 0.00 0.00 171014000.00 10578000.00 10639000.00 15868000.00 0.00 0.00 0.00 0.00 549000.00 0.00 0.00 0.00 0.00
    20 Common Stock Repurchased -653000.00 -150300000.00 -242600000.00 -200100000.00 -211500000.00 70000000.00 81400000.00 75100000.00 28600000.00 25400000.00 12600000.00 10900000.00 171000000.00 9600000.00 0.00 15900000.00 5000000.00 3100000.00 29300000.00 900000.00 0.00 300000.00 1100000.00 1600000.00 59800000.00
    21 Dividends Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Financing Activities 0.00 1231100000.00 1230400000.00 -21600000.00 -334700000.00 2649600000.00 806000000.00 838720000.00 3888529000.00 720006000.00 348050000.00 0.00 0.00 0.00 27908000.00 0.00 0.00 0.00 0.00 0.00 1000.00 0.00 0.00 0.00 0.00
    23 Net Cash Used Provided by Financing Activities -659000.00 -431500000.00 -404800000.00 -309200000.00 -670700000.00 -947400000.00 -525100000.00 -248800000.00 3328100000.00 7700000.00 -167600000.00 -288600000.00 2311100000.00 -22500000.00 90599000.00 14900000.00 3900000.00 2300000.00 1000000.00 4900000.00 -165000.00 -2400000.00 6000000.00 -400000.00 65300000.00
    24 Net Change in Cash 99000.00 -64900000.00 126100000.00 -7800000.00 57100000.00 -244800000.00 -86400000.00 262100000.00 -151900000.00 196700000.00 222400000.00 197500000.00 -4700000.00 70500000.00 -84071000.00 45700000.00 23200000.00 -700000.00 33100000.00 -10000000.00 -13730000.00 -11900000.00 20300000.00 -700000.00 15900000.00
  • About
    Industry: Medical Instruments & Supplies
    Sector: Healthcare
    Country: US
    IPO Date: 3/1/1990
    Stonk Exchange: NASDAQ
    • Hologic, Inc
    • engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women.
    • The company is headquartered in Marlborough, Massachusetts and currently employs 6,478 full-time employees.
    • The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.
    • The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
    • The company offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1).
    • The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems.
    • The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System.
    • The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.